FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100027642> ?p ?o ?g. }

• W2100027642 endingPage "113" @default.
• W2100027642 startingPage "102" @default.
• W2100027642 abstract "Minority patients with hypertension generally require combination therapy to reach blood pressure (BP) goals. We examined the BP-lowering efficacy and safety of combination aliskiren/amlodipine therapy in self-identified minority patients in the United States with stage 2 hypertension and the impact of adding hydrochlorothiazide (HCTZ) to this combination. In this 8-week double-blind study, 412 patients were randomized to receive aliskiren/amlodipine (150/5 mg) or amlodipine (5 mg) with forced titration up to aliskiren/amlodipine/HCTZ (300/10/25 mg) or aliskiren/amlodipine (300/10 mg), respectively. Overall, mean age was 55.2 years, mean body mass index was 32 kg/m2, 62.3% were black, 28.2% were Hispanic/Latino, and 69.1% had metabolic syndrome. Mean sitting systolic blood pressure (MSSBP), the primary efficacy outcome, was reduced from 167.1 mm Hg at baseline to 130.7 mm Hg at week 8 with aliskiren/amlodipine/HCTZ and from 167.4 mm Hg to 137.9 mm Hg with aliskiren/amlodipine (P < .0001 between groups). At week 8, BP goal (<140/90 mm Hg) was achieved in 72.6% and 53.2% of patients in the two treatment groups, respectively (P < .0001). Adverse events were experienced by 34.2% and 40.2%, respectively. Combination aliskiren/amlodipine therapy was effective in treating these high-risk patients but inclusion of HCTZ provided greater antihypertensive efficacy. Both treatments were similarly well tolerated." @default.
• W2100027642 created "2016-06-24" @default.
• W2100027642 creator A5002458693 @default.
• W2100027642 creator A5026477105 @default.
• W2100027642 creator A5045527630 @default.
• W2100027642 creator A5046186654 @default.
• W2100027642 creator A5071877865 @default.
• W2100027642 creator A5086518163 @default.
• W2100027642 date "2011-03-01" @default.
• W2100027642 modified "2023-09-27" @default.
• W2100027642 title "Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension" @default.
• W2100027642 cites W1965305690 @default.
• W2100027642 cites W1981431306 @default.
• W2100027642 cites W1984672931 @default.
• W2100027642 cites W1995489710 @default.
• W2100027642 cites W1996247186 @default.
• W2100027642 cites W1997593082 @default.
• W2100027642 cites W2010787529 @default.
• W2100027642 cites W2022057294 @default.
• W2100027642 cites W2023889957 @default.
• W2100027642 cites W2031278591 @default.
• W2100027642 cites W2034748407 @default.
• W2100027642 cites W2072734363 @default.
• W2100027642 cites W2083330358 @default.
• W2100027642 cites W2087879795 @default.
• W2100027642 cites W2097996074 @default.
• W2100027642 cites W2106982105 @default.
• W2100027642 cites W2110880027 @default.
• W2100027642 cites W2114317624 @default.
• W2100027642 cites W2121332703 @default.
• W2100027642 cites W2121754021 @default.
• W2100027642 cites W2130292002 @default.
• W2100027642 cites W2134422033 @default.
• W2100027642 cites W2137757612 @default.
• W2100027642 cites W2143484421 @default.
• W2100027642 cites W2143954917 @default.
• W2100027642 cites W2166520734 @default.
• W2100027642 cites W2168326627 @default.
• W2100027642 cites W2170008703 @default.
• W2100027642 cites W2172164753 @default.
• W2100027642 cites W2303651371 @default.
• W2100027642 cites W2562329777 @default.
• W2100027642 cites W4248446744 @default.
• W2100027642 doi "https://doi.org/10.1016/j.jash.2011.01.006" @default.
• W2100027642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21414565" @default.
• W2100027642 hasPublicationYear "2011" @default.
• W2100027642 type Work @default.
• W2100027642 sameAs 2100027642 @default.
• W2100027642 citedByCount "26" @default.
• W2100027642 countsByYear W21000276422012 @default.
• W2100027642 countsByYear W21000276422013 @default.
• W2100027642 countsByYear W21000276422014 @default.
• W2100027642 countsByYear W21000276422015 @default.
• W2100027642 countsByYear W21000276422017 @default.
• W2100027642 countsByYear W21000276422020 @default.
• W2100027642 countsByYear W21000276422022 @default.
• W2100027642 crossrefType "journal-article" @default.
• W2100027642 hasAuthorship W2100027642A5002458693 @default.
• W2100027642 hasAuthorship W2100027642A5026477105 @default.
• W2100027642 hasAuthorship W2100027642A5045527630 @default.
• W2100027642 hasAuthorship W2100027642A5046186654 @default.
• W2100027642 hasAuthorship W2100027642A5071877865 @default.
• W2100027642 hasAuthorship W2100027642A5086518163 @default.
• W2100027642 hasConcept C126322002 @default.
• W2100027642 hasConcept C126894567 @default.
• W2100027642 hasConcept C197934379 @default.
• W2100027642 hasConcept C198710026 @default.
• W2100027642 hasConcept C2776999253 @default.
• W2100027642 hasConcept C2779646130 @default.
• W2100027642 hasConcept C2779838083 @default.
• W2100027642 hasConcept C2780361556 @default.
• W2100027642 hasConcept C71924100 @default.
• W2100027642 hasConcept C84393581 @default.
• W2100027642 hasConcept C98274493 @default.
• W2100027642 hasConceptScore W2100027642C126322002 @default.
• W2100027642 hasConceptScore W2100027642C126894567 @default.
• W2100027642 hasConceptScore W2100027642C197934379 @default.
• W2100027642 hasConceptScore W2100027642C198710026 @default.
• W2100027642 hasConceptScore W2100027642C2776999253 @default.
• W2100027642 hasConceptScore W2100027642C2779646130 @default.
• W2100027642 hasConceptScore W2100027642C2779838083 @default.
• W2100027642 hasConceptScore W2100027642C2780361556 @default.
• W2100027642 hasConceptScore W2100027642C71924100 @default.
• W2100027642 hasConceptScore W2100027642C84393581 @default.
• W2100027642 hasConceptScore W2100027642C98274493 @default.
• W2100027642 hasIssue "2" @default.
• W2100027642 hasLocation W21000276421 @default.
• W2100027642 hasLocation W21000276422 @default.
• W2100027642 hasOpenAccess W2100027642 @default.
• W2100027642 hasPrimaryLocation W21000276421 @default.
• W2100027642 hasRelatedWork W1990031829 @default.
• W2100027642 hasRelatedWork W2031482824 @default.
• W2100027642 hasRelatedWork W2075354764 @default.
• W2100027642 hasRelatedWork W2084697582 @default.
• W2100027642 hasRelatedWork W2100027642 @default.
• W2100027642 hasRelatedWork W2113583700 @default.
• W2100027642 hasRelatedWork W2331963729 @default.
• W2100027642 hasRelatedWork W2417752632 @default.

• next